{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:17:21Z","timestamp":1790702241502,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2298-8","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T13:30:28Z","timestamp":1488893428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan"],"prefix":"10.1186","volume":"17","author":[{"given":"Shuji","family":"Hatakeyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Nukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoji","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"issue":"12","key":"2298_CR1","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1086\/504381","volume":"42","author":"MA Groote De","year":"2006","unstructured":"De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis. 2006;42(12):1756\u201363.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2298_CR2","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1128\/AAC.00402-06","volume":"50","author":"KA Nash","year":"2006","unstructured":"Nash KA, Andini N, Zhang Y, Brown-Elliott BA, Wallace Jr RJ. Intrinsic macrolide resistance in rapidly growing mycobacteria. Antimicrob Agents Chemother. 2006;50(10):3476\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl","key":"2298_CR3","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1472-9792(13)70005-2","volume":"93","author":"ST Howard","year":"2013","unstructured":"Howard ST. Recent progress towards understanding genetic variation in the Mycobacterium abscessus complex. Tuberculosis. 2013;93(Suppl):S15\u201320.","journal-title":"Tuberculosis"},{"issue":"Pt 2","key":"2298_CR4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1099\/ijs.0.65222-0","volume":"58","author":"B Lamy","year":"2008","unstructured":"Lamy B, Marchandin H, Hamitouche K, Laurent F. Mycobacterium setense sp. nov., a Mycobacterium fortuitum-group organism isolated from a patient with soft tissue infection and osteitis. Int J Syst Evol Microbiol. 2008;58(Pt 2):486\u201390.","journal-title":"Int J Syst Evol Microbiol"},{"key":"2298_CR5","doi-asserted-by":"crossref","first-page":"854078","DOI":"10.1155\/2015\/854078","volume":"2015","author":"MC Mediavilla-Gradolph","year":"2015","unstructured":"Mediavilla-Gradolph MC, De Toro-Peinado I, Bermudez-Ruiz MP, Garcia-Martinez Mde L, Ortega-Torres M, Montiel Quezel-Guerraz N, et al. Use of MALDI-TOF MS for Identification of Nontuberculous Mycobacterium Species Isolated from Clinical Specimens. Biomed Res Int. 2015;2015:854078.","journal-title":"Biomed Res Int"},{"issue":"4","key":"2298_CR6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","volume":"53","author":"KA Nash","year":"2009","unstructured":"Nash KA, Brown-Elliott BA, Wallace Jr RJ. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother. 2009;53(4):1367\u201376.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"2298_CR7","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/rccm.201111-2005OC","volume":"186","author":"GE Choi","year":"2012","unstructured":"Choi GE, Shin SJ, Won CJ, Min KN, Oh T, Hahn MY, et al. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance. Am J Respir Crit Care Med. 2012;186(9):917\u201325.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2298_CR8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.clinthera.2006.08.011","volume":"28","author":"TL Doan","year":"2006","unstructured":"Doan TL, Fung HB, Mehta D, Riska PF. Tigecycline: a glycylcycline antimicrobial agent. Clin Ther. 2006;28(8):1079\u2013106.","journal-title":"Clin Ther"},{"issue":"10","key":"2298_CR9","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1128\/AAC.46.10.3164-3167.2002","volume":"46","author":"RJ Wallace Jr","year":"2002","unstructured":"Wallace Jr RJ, Brown-Elliott BA, Crist CJ, Mann L, Wilson RW. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother. 2002;46(10):3164\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2298_CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1684-1182(10)60063-1","volume":"43","author":"YC Huang","year":"2010","unstructured":"Huang YC, Liu MF, Shen GH, Lin CF, Kao CC, Liu PY, et al. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing. J Microbiol Immunol Infect. 2010;43(5):401\u20136.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"2298_CR11","first-page":"73","volume":"35","author":"C Cavusoglu","year":"2012","unstructured":"Cavusoglu C, Gurpinar T, Ecemis T. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel. New Microbiol. 2012;35(1):73\u20136.","journal-title":"New Microbiol"},{"issue":"3","key":"2298_CR12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijantimicag.2012.10.021","volume":"41","author":"CW Huang","year":"2013","unstructured":"Huang CW, Chen JH, Hu ST, Huang WC, Lee YC, Huang CC, et al. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan. Int J Antimicrob Agents. 2013;41(3):218\u201323.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"2298_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diagmicrobio.2014.10.007","volume":"81","author":"SY Kim","year":"2015","unstructured":"Kim SY, Kim CK, Bae IK, Jeong SH, Yim JJ, Jung JY, et al. The drug susceptibility profile and inducible resistance to macrolides of Mycobacterium abscessus and Mycobacterium massiliense in Korea. Diagn Microbiol Infect Dis. 2015;81(2):107\u201311.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2298_CR14","first-page":"419392","volume":"2015","author":"H Pang","year":"2015","unstructured":"Pang H, Li G, Zhao X, Liu H, Wan K, Yu P. Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China. Biomed Res Int. 2015;2015:419392.","journal-title":"Biomed Res Int"},{"issue":"11","key":"2298_CR15","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1128\/AAC.03539-14","volume":"58","author":"Y Horita","year":"2014","unstructured":"Horita Y, Maeda S, Kazumi Y, Doi N. In vitro susceptibility of Mycobacterium tuberculosis isolates to an oral carbapenem alone or in combination with beta-lactamase inhibitors. Antimicrob Agents Chemother. 2014;58(11):7010\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"2298_CR16","volume-title":"Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes; Approved Standard\u2013Second edition. CLSI document M24-A2","author":"CLSI","year":"2011","unstructured":"CLSI. Susceptibility testing of Mycobacteria, Nocardia, and other aerobic actinomycetes; Approved Standard\u2013Second edition. CLSI document M24-A2. Wayne: Clinical and Laboratory Standards Institute; 2011."},{"issue":"5","key":"2298_CR17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0463.2006.apm_390.x","volume":"114","author":"B Petrini","year":"2006","unstructured":"Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS. 2006;114(5):319\u201328.","journal-title":"APMIS"},{"issue":"7","key":"2298_CR18","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/jac\/dku062","volume":"69","author":"RJ Wallace Jr","year":"2014","unstructured":"Wallace Jr RJ, Dukart G, Brown-Elliott BA, Griffith DE, Scerpella EG, Marshall B. Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections. J Antimicrob Chemother. 2014;69(7):1945\u201353.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"2298_CR19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jac\/dkh523","volume":"55","author":"KA Nash","year":"2005","unstructured":"Nash KA, Zhang Y, Brown-Elliott BA, Wallace Jr RJ. Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. J Antimicrob Chemother. 2005;55(2):170\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2298_CR20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","volume":"183","author":"WJ Koh","year":"2011","unstructured":"Koh WJ, Jeon K, Lee NY, Kim BJ, Kook YH, Lee SH, et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med. 2011;183(3):405\u201310.","journal-title":"Am J Respir Crit Care Med"},{"key":"2298_CR21","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1469-0691.2009.02757.x","volume":"15","author":"J Esteban","year":"2009","unstructured":"Esteban J, Martin-de-Hijas NZ, Garcia-Almeida D, Bodas-Sanchez A, Gadea I, Fernandez-Roblas R. Prevalence of erm methylase genes in clinical isolates of non-pigmented, rapidly growing mycobacteria. Clin Microbiol Infect. 2009;15:919\u201323.","journal-title":"Clin Microbiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2298-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T12:05:22Z","timestamp":1498392322000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2298-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2298"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2298-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]},"article-number":"197"}}